LVAD Monitoring App Recall; ADHD Drug & CVD Risk; Value of ATTR Treatments?

(MedPage Today) -- The FDA announced the class I recall of an Abbott app used to monitor patients using the HeartMate 3 Left Ventricular Assist Device (LVAD), as well as updated guidance related to the troublesome "Stop Pump" command; the recall...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news